Catalyst
Slingshot members are tracking this event:
Eyenovia's (EYEN) Phase 3 VISION-1 study evaluating MicroLine for the treatment of presbyopia topline data on track for Q2 Release
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EYEN | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 25, 2021
Occurred Source:
https://ir.eyenovia.com/news-releases/news-release-details/eyenovia-announces-positive-topline-results-vision-1-phase-3
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vision-1, Microline, Presbyopia
